Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 360 (9350), 2031-2038
- https://doi.org/10.1016/s0140-6736(02)12021-6
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trialThe Lancet, 2001
- The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burdenThe American Journal of Tropical Medicine and Hygiene, 2001
- The public health impact of chloroquine resistance in AfricaThe American Journal of Tropical Medicine and Hygiene, 2001
- Toward a framework and indicators for monitoring Roll Back Malaria.The American Journal of Tropical Medicine and Hygiene, 2001
- The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya.The American Journal of Tropical Medicine and Hygiene, 2000
- Averting a malaria disasterThe Lancet, 1999
- Antimalarial drug resistance and combination chemotherapyPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1999
- Clinical Pharmacology and Therapeutic Potential of Artemisinin and its Derivatives in the Treatment of MalariaDrugs, 1996
- Can amodiaquine be resurrected?The Lancet, 1996
- Systematic review of amodiaquine treatment in uncomplicated malariaThe Lancet, 1996